… the context of multimodal treatment strategies aimed at the … muscle mass plasticity for the
treatment of muscle wasting. Keywords: Muscle plasticity, Glycogen synthase kinase-3, muscle …

… From basic science, new therapeutic targets were shown including RNAsome, piRNAs, …
of muscle wasting and cachexia and the potential epigenetic treatment targets were presented …

… target for the treatment of muscle atrophy. … and treatment of muscle wasting in patients with
cancer (POWER)” evaluating enobosarm for the prevention and treatment of muscle wasting …

… -like syndrome with muscle wasting and fat loss 9 . Because of the well-established impact
of myostatin signaling on muscle mass, a number of agents that target the myostatin signaling …

… potential for pharmaceutical drugs able to treat muscle wasting when it becomes deleterious.
This review presents an overview of the main pathways contributing to UPS activation in …

… Activin and Act-R ligands are becoming increasingly important as triggers of muscle
wasting and as pharmacological targets to treat cachexia; however, because follistatin alone is …

… exercise required to sufficiently target muscle mass, particularly in a … trials to target muscle
wasting is provided in Table 1. … the impact of cancer treatments on muscle wasting using single …

… of β2-agonists in the treatment of muscle wasting. This review examines the … muscle wasting,
and the potential interest of β2-agonist administration for the treatment of muscle wasting in …

… Large fat reserves notwithstanding, muscle wasting continues. The reported … in the TARGET
study, so muscle wasting may simply be a consequence of disease progression. Muscle loss …

… In humans, testosterone targets satellite cells to prevent the age-related myocyte apoptosis.
… confirmed these results on muscle mass and function in response to the treatment of DHEA. …